Chlamydia incidence - 313 per MDPH BID STD Surveillance among adults and 349 per 100,000 100,000 Program 2011 adolescents 36 per 100,000 29 per 155 per 100,000 100,000 for ages 124 per MDPH BID STD Surveillance Gonorrhea incidence 20-24 100,000 Program 2011 106 per 85 per 100,000 for ages 100,000 25-29 Gonorrhea incidence 175 cases per 126 per MDPH BID STD Surveillance Blacks 100,000 100,000 Program 2011 Gonorrhea incidence MDPH BID STD Surveillance 44 cases per 38 per among Program 2011 100,000 100,000 Hispanics/Latinos Syphilis incidence MDPH BID STD Surveillance – 363 cases in the among men who have 269 cases Program 2011 MSM population sex with men (MSM) Reported sexually transmitted infections Numerator: Total MA population by age, race, and ethnicity (US Census Denominator: Bureau); N/A for MSM Exclusions: None Timeframe: Quarterly How will this be Routine disease surveillance (See Appendix D) measured? Inform, Educate, and Empower People About Health Issues 3.3.1 Establish and promote comprehensive sex education for middle school and high school to enhance prevention of sexually transmitted infections (STIs), and track whether this education reduces disease rates in high risk populations. 3.3.2 Educate and train providers about evidence-based treatment, resources, available referral services, and culturally and linguistically appropriate interventions. 3.3.3 Enhance levels of immunization of adolescents with HPV vaccine through provider and public education. 3.3.4 Promote condom use and availability among sexually active youth and adults. Link People to Needed Personal Health Services and Health Care 3.3.5 Increase screening for STIs (chlamydia, gonorrhea and syphilis) in at risk populations (adolescents, minorities, and men who have sex with men). Standard 3D: Reduce morbidity and mortality related to HIV/AIDS. Measure 3.4: Decrease the incidence of newly diagnosed HIV infections overall and among men who have sex with men (MSM) to meet multiple specified targets, and reduce racial and ethnic HIV infection disparities by 20%. Outcome Indicator Baseline 2020 Target Data Source
Chlamydia incidence - among adults and adolescents 349 per 100,000 313 per 100,000 MDPH BID STD Surveillance Program 2011 Gonorrhea incidence 36 per 100,000 155 per 100,000 for ages 20-24 106 per 100,000 for ages 25-29 29 per 100,000 124 per 100,000 85 per 100,000 MDPH BID STD Surveillance Program 2011 Gonorrhea incidence Blacks 175 cases per 100,000 126 per 100,000 MDPH BID STD Surveillance Program 2011 Gonorrhea incidence among Hispanics/Latinos 44 cases per 100,000 38 per 100,000 MDPH BID STD Surveillance Program 2011 Syphilis incidence – among men who have sex with men (MSM) 363 cases in the MSM population 269 cases MDPH BID STD Surveillance Program 2011 Numerator: Reported sexually transmitted infections Denominator: Total MA population by age, race, and ethnicity (US Census Bureau); N/A for MSM Exclusions: None Timeframe: Quarterly How will this be measured? Routine disease surveillance (See Appendix D) Inform, Educate, and Empower People About Health Issues 3.3.1 Establish and promote comprehensive sex education for middle school and high school to enhance prevention of sexually transmitted infections (STIs), and track whether this education reduces disease rates in high risk populations. 3.3.2 Educate and train providers about evidence-based treatment, resources, available referral services, and culturally and linguistically appropriate interventions. 3.3.3 Enhance levels of immunization of adolescents with HPV vaccine through provider and public education. 3.3.4 Promote condom use and availability among sexually active youth and adults. Link People to Needed Personal Health Services and Health Care 3.3.5 Increase screening for STIs (chlamydia, gonorrhea and syphilis) in at risk populations (adolescents, minorities, and men who have sex with men). Standard 3D: Reduce morbidity and mortality related to HIV/AIDS. Measure 3.4: Decrease the incidence of newly diagnosed HIV infections overall and among men who have sex with men (MSM) to meet multiple specified targets, and reduce racial and ethnic HIV infection disparities by 20%. Outcome Indicator Baseline 2020 Target Data Source